Eli Lilly sued four telehealth firms and their affiliates, but it is adopting a new legal strategy in its fight against compounded GLP-1s. Skip to Main Content Manage alerts for this article ...

Compounders lose legal battle with FDA over removal of Eli ... A federal judge has sided with the U.S. Food and Drug Administration over a decision last year to remove two Eli Lilly drugs ...

Eli Lilly And Co (NYSE:LLY) has issued a series of cease-and-desist letters to U.S. healthcare providers, ... Also Read: Eli Lilly’s Legal Battle Against Fake Compounded Tirzepatide Products: ...

Houston Chronicle. Julian Gill on the legal battle between Eli Lilly, Empower Houston. Posted: May 6, 2025 | Last updated: May 16, 2025. Houston Chronicle reporter Julian Gill discusses his recent ...

The move intensifies an ongoing legal battle, as Novo Nordisk joins its major competitor Eli Lilly in opposing a recent initiative by the Outsourcing Facilities Association to include liraglutide ...

April 23 (UPI) --Eli Lilly Wednesday filed lawsuits against four telehealth companies alleging they are deceiving consumers by selling compounds of slightly-different versions of Lilly drugs ...

Novo Nordisk and Eli Lilly are moving to end compounding of their medicines for good. They say they are no longer in shortage (a necessary condition for legal compounding in this case), and that ...

Amid ongoing battles over alternate supplies of blockbuster weight loss drugs, Eli Lilly filed new lawsuits against four telehealth firms and their affiliates, but is using a new line of attack &# ...

A federal judge has sided with the FDA over a decision last year to remove two Eli Lilly drugs — the Zepbound weight loss medicine and the Mounjaro diabetes treatment — from a shortages list ...